Palantir: The Digital Tool of Imperialist Surveillance and Exploitation

Fyfe Hall, Trinity Centre

Saturday, 4th April 16:00 – 17:10

The talk is aimed at exposing what Palantir truly is and what it is doing in the U.K and abroad. It is not merely a tech company, but the emergent surveillance tool of the imperialist state a monopoly that fuses finance capital with the state apparatus to perfect surveillance, social control, and the war profiteering.

This talk will argue that Palantir represents a new stage in the centralization and state intellignece. It has grown into a $450 billion behemoth by becoming indispensable to the military-industrial complex, its algorithms now selecting targets for assassination and managing the deportation of immigrants. Its software platforms act as the central nervous system for the capitalist state, managing everything from disease surveillance to the "efficiency" of welfare payments. This is not innovation for social good; it is the rationalization of the state's role as an instrument of class rule, optimizing repression and resource extraction for the ruling class while creating a new frontier for capital accumulation.

We will examine how Palantir is deeply intertwined with the ruling class of the imperialist core, with politicians across the spectrum investing in its stock, creating a seamless fusion of political power and corporate profit. This analysis will connect Palantir's role in Palestine, and the UK's NHS and how this is a attempt to control the NHS by private industry and use patient’s data for surveillance  on the working class.

For a movement dedicated to social transformation, understanding Palantir is critical. It is the architecture of our  oppression and the tool for our present management. We will conclude by providing : 

  • Tactics on how to push back against Palantir in the NHS.
  • Expose how wretched this company is
  • Ask people to join in the campaigns in Bristol

This session will be delivered by activists working locally and nationally on the No Palantir in the NHS campaign.